ProCE Banner Activity

Antibody–Drug Conjugates in TNBC

Slideset Download
Download these slides for expert insights into approved and emerging antibody–drug conjugates for managing TNBC, including sacituzumab govitecan, ladiratuzumab vedotin, and more.

Released: December 08, 2020

Expiration: December 07, 2021

No longer available for credit.

Share

Faculty

Kevin Kalinsky

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia